Results 41 to 50 of about 21,724 (252)
Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia
Neuroendocrinology, 2019 An appropriate diagnostic evaluation is essential for the most appropriate treatment to be performed. Currently, macroprolactinemia is the third most frequent cause of nonphysiological hyperprolactinemia after drugs and prolactinomas.
L. Vilar +3 more
semanticscholar +1 more source
International Journal of Environmental Research and Public Health, 2020 Hyperprolactinemia (hPRL) often poses a diagnostic dilemma due to the presence of macroprolactin. Understanding the prevalence of macroprolactinemia (mPRL) has an important implication in managing patients with hPRL.
Noor Azlin Azraini Che Soh +7 more
semanticscholar +1 more source
Tamsulosin-induced Hyperprolactinemia in a Patient with Multiple Sclerosis: A Case Report
Journal of Urological Surgery, 2019 Drug-induced hyperprolactinemia is one of the most common causes of non-physiologic hyperprolactinemia. In contrary to other anterior pituitary hormones, prolactin is not controlled via hypothalamic-pituitary negative feedback mechanism.
Ahmet Görgel +4 more
doaj +1 more source
Kaohsiung Journal of Medical Sciences, 2012 This study investigated the differences in clinical and laboratory features as well as treatment response in 70 outpatients with macroprolactinemia and monomeric hyperprolactinemia treated with dopamine agonists.
Chih-Chin Lu, Ching-Jung Hsieh
doaj +1 more source
PCOS and Hyperprolactinemia: what do we know in 2019?
Clinical Medicine Insights: Reproductive Health, 2019 Polycystic ovary syndrome (PCOS) and hyperprolactinemia (HPRL) are the two most common etiologies of anovulation in women. Since the 1950s, some authors think that there is a pathophysiological link between PCOS and HPRL.
Clémence Delcour +3 more
semanticscholar +1 more source
Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines? [PDF]
РМЖ. Мать и дитя, 2020 Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines? A.A. Olina D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproduction, St.
A.A. Olina
doaj
Etiopathogenetic features of hyperprolactinemia in childhood
Zdorovʹe Rebenka, 2021 In recent years, the problem of hyperprolactinemia in children remains relevant because it is one of the most common pathologies of the hypothalamic-pituitary system, causing impaired fertility and reproductive function in adulthood.
O.E. Abaturov +2 more
doaj +1 more source
European Journal of Endocrinology, 2019 Background Dopamine agonists (DAs) are the main treatment for patients with hyperprolactinemia and prolactinomas. Recently, an increasing number of reports emphasized DAs' psychological side effects, either de novo or as exacerbations of prior ...
A. Ioachimescu +4 more
semanticscholar +1 more source
Olanzapine-Induced Hyperprolactinemia: Two Case Reports
Frontiers in Pharmacology, 2019 Background: Hyperprolactinemia is a common consequence of treatment with antipsychotics. It is usually defined by a sustained prolactin level above the laboratory upper level of normal in conditions other than that where physiologic hyperprolactinemia is
Pedro Cabral Barata +3 more
doaj +1 more source
Radiological features of breast benign lesions in patients with hyperprolactinemia [PDF]
Archive of Oncology, 2007 Background: The study was conducted to determine whether prolactin (PRL) influences radiological features of benign breast lesions. Methods: During the 4-year period, we observed 50 patients with nipple discharge: 23 with normal serum prolactin levels ...
Radojković Danijela +5 more
doaj +1 more source